Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9779717rdf:typepubmed:Citationlld:pubmed
pubmed-article:9779717lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0205851lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0015133lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0332154lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:9779717lifeskim:mentionsumls-concept:C1511559lld:lifeskim
pubmed-article:9779717pubmed:issue10lld:pubmed
pubmed-article:9779717pubmed:dateCreated1998-10-26lld:pubmed
pubmed-article:9779717pubmed:abstractTextHigh cumulative epipodophyllotoxin dosages are reported to be associated with an elevated risk for secondary acute myeloid leukemia (s-AML). This study examined the risk of s-AML following cumulative etoposide doses greater than 2 g/m2 in patients with metastatic germ cell tumors (GCT).lld:pubmed
pubmed-article:9779717pubmed:languageenglld:pubmed
pubmed-article:9779717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9779717pubmed:citationSubsetIMlld:pubmed
pubmed-article:9779717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9779717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9779717pubmed:statusMEDLINElld:pubmed
pubmed-article:9779717pubmed:monthOctlld:pubmed
pubmed-article:9779717pubmed:issn0732-183Xlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:BeyerJJlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:BironPPlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:DrozJ PJPlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:SchmollH JHJlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:BokemeyerCClld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:KanzLLlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:HarstrickAAlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:SchöffskiPPlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:HartmannJ TJTlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:KuczykMMlld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:Kollmannsberg...lld:pubmed
pubmed-article:9779717pubmed:authorpubmed-author:FléchonAAlld:pubmed
pubmed-article:9779717pubmed:issnTypePrintlld:pubmed
pubmed-article:9779717pubmed:volume16lld:pubmed
pubmed-article:9779717pubmed:ownerNLMlld:pubmed
pubmed-article:9779717pubmed:authorsCompleteYlld:pubmed
pubmed-article:9779717pubmed:pagination3386-91lld:pubmed
pubmed-article:9779717pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:meshHeadingpubmed-meshheading:9779717-...lld:pubmed
pubmed-article:9779717pubmed:year1998lld:pubmed
pubmed-article:9779717pubmed:articleTitleSecondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.lld:pubmed
pubmed-article:9779717pubmed:affiliationDepartment of Hematology/Oncology, University of Tuebingen Medical Center, Germany.lld:pubmed
pubmed-article:9779717pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9779717pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9779717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9779717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9779717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9779717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9779717lld:pubmed